What is PE-22-28 Peptide?
PE-22-28 is a synthetic peptide derived from diazepam-binding inhibitor (DBI), primarily studied for its potential effects on the central nervous system. Research highlights its role in modulating neuronal activity, making it a subject of interest for cognitive and neuroprotective research.
Key Research Benefits of PE-22-28
Studies suggest the peptide’s primary applications include:
- Promoting neurogenesis by encouraging the growth of new neurons.
- Potential modulation of stress response and anxiety-related biomarkers.
- Investigating cognitive enhancement through neural protection.
- Contributing to studies on synaptic plasticity and memory formation.
How Does PE-22-28 Work?
PE-22-28 functions by influencing the GABAA receptor complex through diazepam-binding inhibitor pathways. This interaction may assist in crossing the blood-brain barrier (BBB), allowing it to exert neurological effects. Its action helps researchers better understand neural communication and stress-response systems.
Technical & Storage Specifications
The following table outlines essential technical details for handling:
| Specification | Details |
|---|---|
| Purity | >99% |
| Appearance | Lyophilized powder |
| Storage | Store at -20°C. After reconstitution, refrigerate between 2-8°C and use within 7 days. |
FAQs
What is the difference between P21 and P022?
P21 and P022 are distinct peptides with separate origins and applications. Researchers should refer to each peptide’s specifications for accurate differentiation.
How should it be stored after reconstitution?
Once reconstituted, PE-22-28 should be refrigerated at 2-8°C and used within 7 days to maintain performance integrity.
Is third-party testing (CoA) available?
Yes, certificates of analysis (CoAs) from third-party labs are available upon request to verify purity and consistency.
Reviews
There are no reviews yet.